American Thoracic Society (ATS)

Innovative Communication System Protects Health Professionals Treating Infectious Disease Patients

Newswise — May 12, 2020─ Physician-scientists have developed a communication management system built on a telemedicine platform that can help minimize the exposure of health care professionals to highly infectious diseases while still providing personalized patient care, according to a new report published online in the Annals of the American Thoracic Society.

In “The Isolation Communication Management System (iSOCOMS): A Telemedicine Platform to Care for Patients in a Biocontainment Unit,” Kyle B. Enfield, MD, MS and colleagues from the University of Virginia Health System report on the development and use of this system during the 2014-2016 Ebola virus outbreak. iSOCOMS is currently being used in the health system’s emergency department and inpatient units to provide protection during the COVID-19 pandemic.

“The exposure of patients, caregivers and health care workers to the Ebola virus during the 2014-2016 outbreak highlighted the critical need to develop tools that assist in the safe care of patients with Ebola or other highly contagious and lethal infectious diseases,” said Dr. Enfield, associate professor, pulmonary and critical care medicine, University of Virginia Health System.

Dr. Enfield and colleagues describe a novel application of real-time video-enabled interactive services, with the potential to reduce exposure risks for health care professionals caring for patients with Ebola virus while not depleting supplies of PPE.  Using commercially available hardware and software, they developed an internal network of telemedicine technologies to enable them to more safely care for Ebola patients -- the UVAHS Isolation Communication Management System (iSOCOMS).

The iSOCOMS network has provided expanded remote guidance, treatment and supervision capabilities within UVA Medical Center’s biocontainment unit, known as the Special Pathogens Unit (SPU). It also serves a designated biocontainment room in the emergency department.

The system was evaluated during the admission of three patients, who potentially had Ebola, to the SPU over a nine-month period.   iSOCOMS was used, for example, to monitor the movement of a patient from an ambulance to the biocontainment room, where a camera and monitor in the room allowed for communication with health care professionals outside the room. Four case-use scenarios for iSOCOMS were assessed during the Ebola outbreak:

  1. Using iSOCOMS to facilitate communication and reduce staff exposure risk. iSOCOMS enabled at least one staff member to be in the biocontainment room at all times with patients who may have had Ebola but were not critically ill, allowing a second provider to observe from outside the room and assist in patient care. The observer also took notes, unencumbered by PPE, and used an electronic stethoscope through iSOCOMS and a bedside computer.
  2. Using iSOCOMS to facilitate provider-to-provider communication. iSOCOMS also helped patients communicate with their health care providers.  Providers introduced themselves, unencumbered by PPE, and their names were displayed on the monitors.  Providers were also able to interview patients through iSOCOMS.
  3. Improved monitoring of patient and staff. Patient care was audited to assure the safety of both patient and staff.  Video monitoring enabled the observer to watch for and warn against breaches in PPE, in real time.
  4. Monitoring of patient movement into the unit. iSOCOMS monitored patients transported to the medical center, through secured corridors and elevators, into the SPU.  Using iSOCOMS, the safety officer, hospital epidemiologist, SPU medical director, other providers and medical transport team conducted a videoconference using fixed and portable electronic devices.

Although the UVA team did not test other iSOCOMS capabilities during the Ebola crisis, they were able to discuss an additional three: video-enabled consultation; patient support through family, chaplaincy and counseling; and facilitating student/learner involvement.

Speaking for the team, Dr. Enfield added, “The benefits of iSOCOMS in reducing PPE use, improving patient experience, extending the capacity of our workforce and providing a means for providers to see patients in their own hospital without always going into their rooms are clear.  Telemedicine is as vital a tool for inpatient care of COVID as it is for ambulatory care.”

 

Share via Twitter:

Innovative communication system used during #Ebola outbreak now used during #COVID-19 pandemic. @atscommunity @uvahealthnews

 

About the Annals of the American Thoracic Society

The AnnalsATS is a peer-reviewed journal published by the American Thoracic Society. The Journal delivers up-to-date and authoritative coverage of adult and pediatric pulmonary and respiratory sleep medicine and adult critical care. The scope of the Journal encompasses content that is applicable to clinical practice, the formative and continuing education of clinical specialists and the advancement of public health. The journal’s impact factor is 4.026.

Editor: Colin Cooke, MD, MS, associate professor in the department of internal medicine at the University of Michigan.

About the American Thoracic Society

Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes four journals, the American Journal of Respiratory and Critical Care Medicine

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3699
Released: 19-Oct-2020 4:20 PM EDT
Patients Who Had More Severe Covid-19 May Be the Best Donors for Convalescent Plasma Therapy
Johns Hopkins Bloomberg School of Public Health

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease.

access_time Embargo lifts in 2 days
Embargo will expire: 20-Oct-2020 10:00 AM EDT Released to reporters: 19-Oct-2020 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Oct-2020 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Oct-2020 3:05 PM EDT
Experts haven’t changed their estimates for COVID-19 immunity duration, despite Trump's claim
Newswise

We rate this claim as mostly false. Infectious disease experts did not shift from saying immunity was lifelong to saying it lasted only a few months for partisan reasons. Experts haven’t changed their estimates for immunity duration, which remains unknown. Most agree that it is not a "life-time".

Newswise: 246157_web.jpg
Released: 19-Oct-2020 1:50 PM EDT
CBD helps reduce lung damage from COVID by increasing levels of protective peptide
Medical College of Georgia at Augusta University

One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.

Released: 19-Oct-2020 1:35 PM EDT
Fear of COVID-19 raises risk of depression among Soweto's deprived communities
Cambridge University Press

A STUDY into the impact of the COVID-19 lockdown on the mental health of people in Soweto has found a significant link between symptoms of depression and how likely people felt they were to be infected.

Released: 19-Oct-2020 1:25 PM EDT
Coronavirus Test Results Are Faster but Still Too Slow For Contract Tracing, National Survey Says
Rutgers University-New Brunswick

The average test times for coronavirus results have fallen from four days in April to 2.7 days in September, but results are still too slow for effective contact tracing, according to a new nationwide survey led by researchers from Rutgers University–New Brunswick and Northeastern, Harvard and Northwestern universities.

Newswise: 246236_web.jpg
Released: 19-Oct-2020 1:15 PM EDT
Researchers investigate impact of COVID-19 on BAME businesses
Staffordshire University

Black, Asian and Minority Ethnic (BAME) businesses have had to incur considerable costs to protect their businesses through lockdown, according to academics at Staffordshire University.

Released: 19-Oct-2020 1:05 PM EDT
Criteria to predict cytokine storm in COVID-19 patients identified by Temple Researchers
Temple University Health System

Like a cold front that moves in, setting the stage for severe weather, coronavirus infection triggers showers of infection-fighting immune molecules - showers that sometimes escalate into a chaotic immune response known as a cytokine storm.

Newswise: 246249_web.jpg
Released: 19-Oct-2020 12:55 PM EDT
COVID-19 pandemic has dramatic impact on osteoporosis management, finds new global study
International Osteoporosis Foundation

A new study published prior to World Osteoporosis Day finds that the COVID-19 pandemic, which has severely affected management of non-communicable diseases, is markedly impacting the management of osteoporosis as judged by access to online FRAX fracture risk assessments.


Showing results

110 of 3699

close
1.14197